• Mashup Score: 1

    Among new initiators of multiple-inhaler triple therapy for asthma, discontinuation was high, although approximately one-third of patients reinitiated their therapy, researchers reported at the CHEST Annual Meeting.“There is a limited amount of real-world data on treatment patterns after the discontinuation of therapy in the U.S.,” William Shiyuan Zhang, value evidence and outcomes

    Tweet Tweets with this article
    • New data presented at #CHEST2021 found high #discontinuation for multiple #inhaler triple therapy among patients with #asthma @HealioAllergy https://t.co/h5hxJ1oDa8

  • Mashup Score: 0

    Among new initiators of multiple-inhaler triple therapy for asthma, discontinuation was high, although approximately one-third of patients reinitiated their therapy, researchers reported at the CHEST Annual Meeting.“There is a limited amount of real-world data on treatment patterns after the discontinuation of therapy in the U.S.,” William Shiyuan Zhang, value evidence and outcomes

    Tweet Tweets with this article
    • New data presented at #CHEST2021 found high #discontinuation for multiple #inhaler triple therapy among patients with #asthma @HealioAllergy https://t.co/h5hxJ1oDa8

  • Mashup Score: 0

    Among new initiators of multiple-inhaler triple therapy for asthma, discontinuation was high, although approximately one-third of patients reinitiated their therapy, researchers reported at the CHEST Annual Meeting.“There is a limited amount of real-world data on treatment patterns after the discontinuation of therapy in the U.S.,” William Shiyuan Zhang, value evidence and outcomes

    Tweet Tweets with this article
    • New data presented at #CHEST2021 found high #discontinuation for multiple #inhaler triple therapy among patients with #asthma @HealioAllergy https://t.co/0FWuOv0bHk

    • New data presented at #CHEST2021 found high #discontinuation for multiple #inhaler triple therapy among patients with #asthma @HealioAllergy https://t.co/TUdfDaPJ7H

  • Mashup Score: 1

    A pharmacist-led intervention may aid in improving inhaler techniques for patients with asthma and COPD and may have a positive impact on health care resource use, according to results of a pilot study published in Respiratory Medicine.“In recent years, community pharmacists have shifted their role in the health care system from traditional medication dispensers to health care

    Tweet Tweets with this article
    • A pharmacist-led intervention focused on improving #inhaler technique was beneficial in a new pilot randomized controlled trial @HealioAllergy https://t.co/mCFtRnzYNw